Intravenous streptokinase in acute myocardial infarction (I.S.A.M.) trial: serial evaluation of left ventricular function up to 3 years after infarction estimated by radionuclide ventriculography. I.S.A.M. Study Group.

[1]  F. Sheehan.  Measurement of left ventricular function as an endpoint in trials of thrombolytic therapy , 1990 .

[2]  P. Serruys,et al.  Long term improvement in global left ventricular function after early thrombolytic treatment in acute myocardial infarction. Report of a randomised multicentre trial of intracoronary streptokinase in acute myocardial infarction. , 1986, British heart journal.

[3]  S. Kaul,et al.  Effects of successful intravenous reperfusion therapy on regional myocardial function and geometry in humans: a tomographic assessment using two-dimensional echocardiography. , 1989, Journal of the American College of Cardiology.

[4]  A. Nyhuis,et al.  Effect of thrombolysis (streptokinase) on left ventricular function during acute myocardial infarction. , 1986, The American journal of cardiology.

[5]  J. Verdenet,et al.  Effects of early high-dose streptokinase intravenously on left ventricular function in acute myocardial infarction. , 1987, The American journal of cardiology.

[6]  P. Rentrop,et al.  Changes in left ventricular function after intracoronary streptokinase infusion in clinically evolving myocardial infarction. , 1981, American heart journal.

[7]  G. Jablonsky,et al.  Nuclear magnetic resonance and radionuclide angiographic assessment of acute myocardial infarction in a randomized trial of intravenous streptokinase. , 1988, The American journal of cardiology.

[8]  M. Cerqueira,et al.  Ventricular function and infarct size: the Western Washington Intravenous Streptokinase in Myocardial Infarction Trial. , 1988, Journal of the American College of Cardiology.

[9]  M S Golden,et al.  Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. , 1980, The New England journal of medicine.

[10]  R J Callahan,et al.  A modified method for the in vivo labeling of red blood cells with Tc-99m: concise communication. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  C. Costantini,et al.  Consequences of coronary arterial occlusion on remote myocardium: effects of occlusion and reperfusion. , 1975, The American journal of cardiology.

[12]  M. Phelps,et al.  Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography. , 1986, Circulation.

[13]  M. Verani,et al.  Intracoronary thrombolytic therapy in acute myocardial infarction: a prospective, randomized, controlled trial. , 1985, The American journal of cardiology.

[14]  P. Marino,et al.  Effect of streptokinase on left ventricular modeling and function after myocardial infarction: the GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico) Trial. , 1989, Journal of the American College of Cardiology.

[15]  F. Sheehan,et al.  The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial. , 1988, Circulation.

[16]  P. Serruys,et al.  Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction. , 1986, Journal of the American College of Cardiology.

[17]  U. Tebbe,et al.  High dose intravenous streptokinase in acute myocardial infarction , 1983, Clinical cardiology.

[18]  A. Maurer,et al.  Coronary thrombolysis by intravenous streptokinase in acute myocardial infarction: acute and follow-up studies. , 1984, The American journal of cardiology.

[19]  G. Timmis,et al.  The influence of infarction site and size on the ventricular response to coronary thrombolysis. , 1985, Archives of internal medicine.

[20]  H. Henning,et al.  Serial measurements of left ventricular ejection fraction by radionuclide angiography early and late after myocardial infarction. , 1976, The American journal of cardiology.

[21]  F. Sheehan,et al.  Intravenous streptokinase for acute myocardial infarction. Effects on global and regional systolic function. , 1988, Circulation.

[22]  J L Ritchie,et al.  Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. , 1983, The New England journal of medicine.

[23]  J. Ritchie,et al.  Risk stratification for 1 year survival based on characteristics identified in the early hours of acute myocardial infarction. The Western Washington Intracoronary Streptokinase Trial. , 1986, Circulation.

[24]  K. Wegscheider,et al.  Intravenous Short‐term Infusion of Streptokinase in Acute Myocardial Infarction , 1983, Circulation.

[25]  F. Sheehan,et al.  Evolution of left ventricular function after intracoronary thrombolysis for acute myocardial infarction. , 1989, The American journal of cardiology.

[26]  R. Califf,et al.  Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial: influence of infarct location on arterial patency, left ventricular function and mortality. , 1989, Journal of the American College of Cardiology.

[27]  H. White,et al.  Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. , 1987, The New England journal of medicine.

[28]  Logg Mh,et al.  Para-aminosalicylic acid in tuberculosis; early results of clinical trials. , 1947 .

[29]  K. Karsch,et al.  Long-term follow-up after intracoronary streptokinase therapy for acute myocardial infarction. , 1985, American heart journal.